Pharmafile Logo

News and Press Releases

Global End-to-End Solutions Partner to Life Sciences Organisations, AscellaHealth, joins Manchester Science Park

20 February 2024 -- Manchester, UK -- Global healthcare and specialty pharmacy solutions company providing innovative solutions to life sciences and biotech manufacturers, AscellaHealth, is expanding its UK presence with...

Category: Manufacturing and Packing
Posted: February 20, 2024

AscellaHealth
info@ascellahealth.com
AscellaHealth, LLC 1055 Westlakes Drive Suite 175 Berwyn, PA 19312, US

argenx Announces MHRA Licensing of Subcutaneous VYVGART (efgartigimod alfa) for generalised Myasthenia Gravis

VYVGART is now licensed for both intravenous (IV) and self-administered subcutaneous (SC) use in the UK 7 February 2024 -- Gerrards Cross, UK -- argenx UK, part of argenx, a...

Category: Biotechnology
Posted: February 7, 2024

argenx
ukmediainfo@argenx.com
Spaces Gerrards Cross Chalfont Park, Building 1 Gerrards Cross, SL9 0BG

Recipharm, Medspray and Resyca enter into exclusive license agreement to develop nasally-delivered drug products using proprietary soft mist technology

Partnership will help bring breakthroughs in the nasal delivery of fragile biologics and small molecules to market 23 January 2023 -- Stockholm, Sweden -- Recipharm, a leading contract development and...

Category: Drug Delivery
Posted: January 23, 2024

Recipharm

Vetter Becomes a Member of the German Association of Research-Based Pharmaceutical Companies (vfa)

Globally operating CDMO committed to strengthening Germany as a research and production location  Association grants Vetter extraordinary membership vfa recognises the importance of pharmaceutical service providers in drug development and...

Category: Biotechnology, Pharmaceutical
Posted: January 17, 2024

Vetter
Schützenstrasse 87, 88212 Ravensburg

New partnership aims to advance vaccine against MERS coronavirus

CEPI to invest up to $47m to develop and stockpile a ready reserve of emergency MERS vaccine candidate, VTP-500 VTP-500 project with Barinthus Bio and University of Oxford, UK, uses...

Category: Clinical Trials
Posted: January 2, 2024

Barinthus Biotherapeutics
Unit 6-10 Zeus Building Rutherford Avenue Harwell OX11 0DF

Newly established 3PARL consortium to assure global life sciences industry of consistent high standard of GMP supply chain audits

Rephine and Eurofins Healthcare are acting against substandard audit practices with guarantees of the highest quality of inspection services & library reports, from raw materials to finished products 24 October...

Category: Other
Posted: October 25, 2023

Rephine
enquiries@rephine.com
15, Meadway Court, Rutherford Cl, Stevenage SG1 2EF

Additional Analytical Laboratory and Spray Drying Investments

5 October 2023 -- New Jersey, US -- Experic, a contract development and manufacturing organisation (CDMO) and clinical supply services company serving the biopharmaceutical industry, announced today the successful completion of...

Category: Manufacturing and Packing
Posted: October 5, 2023

Experic
info@expericservices.com
2 Clarke Drive, Cranbury, NJ 08512

Shionogi Presents New Ensitrelvir Clinical and Real-World Data Reinforcing Potential Across COVID-19 Populations at ESWI 2023

New exploratory analysis of phase 3 SCORPIO-SR study data in Asia suggests that ensitrelvir may reduce the risk of persistent and new late-onset symptoms associated with long COVID-19 over one...

Category: Clinical Trials
Posted: September 20, 2023

SHIONOGI
contact@shionogi.eu
33 Kingsway, London, WC2B 6UF, UK